Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
The Lancet Regional Health. Europe|May 24, 2021
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020Jessica Flood, Joseph Shingleton, Emma Bennett, et al.
Rheumatology (Oxford, England)|December 11, 2021
Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupusEve M D Smith, Kukatharmini Tharmaratnam, Eslam Al-Abadi, et al.
Lupus|October 4, 2021
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort studyTeresa Giani, Eve Md Smith, Eslam Al-Abadi, et al.
Rheumatology (Oxford, England)|April 11, 2018
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndromeLin Wang, Carlos D Rosé, Kevin P Foley, et al.
Lupus|January 8, 2021
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UKJoseph S Massias, Eve Md Smith, Eslam Al-Abadi, et al.
Annals of the Rheumatic Diseases|October 1, 2018
Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trialsNicolino Ruperto, Hermine I Brunner, Pierre Quartier, et al.
Clinical Immunology (Orlando, Fla.)|May 5, 2022
Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort studyEve M D Smith, Naomi Egbivwie, Andrea L Jorgensen, et al.
Rheumatology (Oxford, England)|January 28, 2021
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritisNicolino Ruperto, Hermine I Brunner, Athimalaipet V Ramanan, et al.
Rheumatology (Oxford, England)|May 9, 2022
Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLEAmandine Charras, Sam Haldenby, Eve M D Smith, et al.
Annals of the Rheumatic Diseases|February 6, 2021
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19Alessia Alunno, Aurélie Najm, Pedro M Machado, et al.
Pageof 16